These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 12579267)
21. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues. Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909 [TBL] [Abstract][Full Text] [Related]
22. Expression of endoglin in choroidal neovascularization. Grisanti S; Canbek S; Kaiserling E; Adam A; Lafaut B; Gelisken F; Szurman P; Henke-Fahle S; Oficjalska-Mlynczak J; Bartz-Schmidt KU Exp Eye Res; 2004 Feb; 78(2):207-13. PubMed ID: 14729353 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related]
24. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin. Schmidt-Weber CB; Letarte M; Kunzmann S; Rückert B; Bernabéu C; Blaser K Int Immunol; 2005 Jul; 17(7):921-30. PubMed ID: 15967783 [TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas. Legan M; Luzar B; Ferlan-Marolt V; Cör A Bosn J Basic Med Sci; 2006 Nov; 6(4):58-63. PubMed ID: 17177652 [TBL] [Abstract][Full Text] [Related]
26. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
27. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
28. Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes. Abu El-Asrar AM; Missotten L; Geboes K Clin Exp Ophthalmol; 2010 Jan; 38(1):57-64; quiz 87. PubMed ID: 20447102 [TBL] [Abstract][Full Text] [Related]
29. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Quintanilla M; Ramirez JR; Pérez-Gómez E; Romero D; Velasco B; Letarte M; López-Novoa JM; Bernabéu C Oncogene; 2003 Sep; 22(38):5976-85. PubMed ID: 12955076 [TBL] [Abstract][Full Text] [Related]
30. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949 [TBL] [Abstract][Full Text] [Related]
31. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Kumar S; Ghellal A; Li C; Byrne G; Haboubi N; Wang JM; Bundred N Cancer Res; 1999 Feb; 59(4):856-61. PubMed ID: 10029075 [TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986 [TBL] [Abstract][Full Text] [Related]
34. Differential levels of soluble endoglin (CD105) in myeloid malignancies. Calabrò L; Fonsatti E; Bellomo G; Alonci A; Colizzi F; Sigalotti L; Altomonte M; Musolino C; Maio M J Cell Physiol; 2003 Feb; 194(2):171-5. PubMed ID: 12494455 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342 [TBL] [Abstract][Full Text] [Related]
36. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis. Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334 [TBL] [Abstract][Full Text] [Related]
37. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. Li C; Guo B; Bernabeu C; Kumar S Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303 [TBL] [Abstract][Full Text] [Related]
38. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. Zhang H; Shaw AR; Mak A; Letarte M J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807 [TBL] [Abstract][Full Text] [Related]
39. FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. Hayrabedyan S; Kyurkchiev S; Kehayov I J Reprod Immunol; 2005 Oct; 67(1-2):87-101. PubMed ID: 16165218 [TBL] [Abstract][Full Text] [Related]
40. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. Bredow S; Lewin M; Hofmann B; Marecos E; Weissleder R Eur J Cancer; 2000 Mar; 36(5):675-81. PubMed ID: 10738134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]